Adipose-Derived Stem Cell Biomaterial for Bone Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for bone tissue regeneration using adipose-derived stem cells (ASCs) face limitations due to large bone defect size, poor oxygen and nutrient diffusion, and cellular survival issues within scaffolds, particularly in critical size bone reconstruction.
Innovation Solution
A multi-dimensional biomaterial comprising osteogenic differentiated autologous ASCs, a ceramic material, and an extracellular matrix that secretes osteoprotegerin (OPG), insulin-like growth factor (IGF1), and stromal cell-derived factor 1-alpha (SDF-1α), utilizing calcium phosphate particles like hydroxyapatite and β-tricalcium phosphate, which enhances cell survival and differentiation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If ASCs are seeded on scaffolds for bone reconstruction, then bone tissue regeneration is promoted, but cellular engraftment and survival are limited due to poor diffusion of oxygen and nutrients
Solution Approach 1:
The patent employs porous scaffold materials with optimized pore size and interconnectivity to enhance oxygen and nutrient diffusion throughout the implant. The porous structure allows adequate mass transport to support cell survival and function in large bone defect reconstructions.
Solution Approach 2:
The patent transitions from traditional 2D scaffold surfaces to 3D multi-dimensional constructs that better mimic native bone architecture. This dimensional enhancement improves cellular engraftment and nutrient diffusion by creating more realistic tissue-like environments for cell proliferation and differentiation.
2Area of stationary object
If the implant size is increased to match critical size bone defects, then bone reconstruction coverage is improved, but cellular survival and engraftment deteriorate due to distance from blood supply
Solution Approach 1:
The patent divides large bone defects into smaller modular segments or uses segmented scaffolds that can be individually vascularized. This segmentation reduces the diffusion distance for oxygen and nutrients while still achieving coverage of the entire defect area through multiple interconnected units.
Solution Approach 2:
The patent incorporates preliminary vascularization strategies by pre-seeding scaffolds with endothelial cells or incorporating vascular channels before implantation. This preliminary action establishes blood supply pathways in advance, enabling cellular survival in larger implant volumes.
3Manufacturing precision
If uniform cellular distribution is achieved through flow perfusion, then osteogenic differentiation is improved, but device complexity increases
Solution Approach 1:
The patent employs self-organizing cell behaviors and spontaneous vascularization mechanisms that eliminate the need for complex external flow perfusion systems. Cells naturally migrate and distribute themselves uniformly within the scaffold through contact guidance and chemotaxis, achieving homogeneous distribution without active pumping or flow control mechanisms.
Data Source
AI summary
The present invention relates to a biomaterial comprising adipose-derived stem cells (ASCs), a ceramic material and an extracellular matrix. In particular, the biomaterial according the present invention secretes osteoprotegerin (OPG), and comprises insulin-like growth factor (IGF1) and stromal cell-derived factor 1-alpha (SDF-1α). The present invention also relates to methods for producing the biomaterial and uses thereof.